REPORTS

Let’s Pullulate and Expand Your Business

Pharmaceutical Chemicals Market - Global Professional Analysis and Forecast to 2026

Oct 11, 2019  |  141 PAGES  |  REPORT CODE: CMM204422
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pharmaceutical Chemicals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.

This report presents the market size and development trends by detailing the Pharmaceutical Chemicals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Chemicals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Chemicals industry and will help you to build a panoramic view of the industrial development.

Pharmaceutical Chemicals Market, By Type:

  • Solvents

  • Reagents/Catalysts

  • KSMs/intermediates

  • Building blocks for APIs/Advanced intermediates

Pharmaceutical Chemicals Market, By Application:

  • OTC

  • Generic

  • Super generic

  • Proprietary

Some of the leading players are as follows:

  • Johnson Matthey

  • Easter Chemical Corporation

  • Lonza Group

  • Akzo Nobel N.V

  • Porton Fine Chemicals

  • Vertellus Holdings LLC

  • AstraZeneca

  • BASF SE

  • Lanxess AG

  • Jubilant Life Sciences

  • Celanese AG

  • Albemarle Corporation

  • Hikal

  • Abbott

  • Dishman Group

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pharmaceutical Chemicals Market: Technology Type Analysis

  • 4.1 Pharmaceutical Chemicals Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pharmaceutical Chemicals Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Solvents

    • 4.3.2 Reagents/Catalysts

    • 4.3.3 KSMs/intermediates

    • 4.3.4 Building blocks for APIs/Advanced intermediates

5 Pharmaceutical Chemicals Market: Product Analysis

  • 5.1 Pharmaceutical Chemicals Product Market Share Analysis, 2018 & 2026

  • 5.2 Pharmaceutical Chemicals Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pharmaceutical Chemicals Market: Application Analysis

  • 6.1 Pharmaceutical Chemicals Application Market Share Analysis, 2018 & 2026

  • 6.2 Pharmaceutical Chemicals Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 OTC

    • 6.3.2 Generic

    • 6.3.3 Super generic

    • 6.3.4 Proprietary

7 Pharmaceutical Chemicals Market: Regional Analysis

  • 7.1 Pharmaceutical Chemicals Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pharmaceutical Chemicals Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Johnson Matthey

    • 9.1.1 Johnson Matthey Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Easter Chemical Corporation

    • 9.2.1 Easter Chemical Corporation Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Lonza Group

    • 9.3.1 Lonza Group Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Akzo Nobel N.V

    • 9.4.1 Akzo Nobel N.V Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Porton Fine Chemicals

    • 9.5.1 Porton Fine Chemicals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Vertellus Holdings LLC

    • 9.6.1 Vertellus Holdings LLC Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 AstraZeneca

    • 9.7.1 AstraZeneca Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 BASF SE

    • 9.8.1 BASF SE Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Lanxess AG

    • 9.9.1 Lanxess AG Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Jubilant Life Sciences

    • 9.10.1 Jubilant Life Sciences Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Celanese AG

    • 9.11.1 Celanese AG Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Albemarle Corporation

    • 9.12.1 Albemarle Corporation Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Hikal

    • 9.13.1 Hikal Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Abbott

    • 9.14.1 Abbott Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Dishman Group

    • 9.15.1 Dishman Group Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 107 Figures and 160 Tables)

  • Figure Solvents Pharmaceutical Chemicals market, 2015 - 2026 (USD Million)

  • Figure Reagents/Catalysts Pharmaceutical Chemicals market, 2015 - 2026 (USD Million)

  • Figure KSMs/intermediates Pharmaceutical Chemicals market, 2015 - 2026 (USD Million)

  • Figure Building blocks for APIs/Advanced intermediates Pharmaceutical Chemicals market, 2015 - 2026 (USD Million)

  • Figure OTC market, 2015 - 2026 (USD Million)

  • Figure Generic market, 2015 - 2026 (USD Million)

  • Figure Super generic market, 2015 - 2026 (USD Million)

  • Figure Proprietary market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pharmaceutical Chemicals market, by country, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Chemicals market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Chemicals market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Chemicals market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Chemicals market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pharmaceutical Chemicals market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Chemicals market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Chemicals market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Johnson Matthey Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Easter Chemical Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lonza Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Akzo Nobel N.V Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Porton Fine Chemicals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vertellus Holdings LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BASF SE Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lanxess AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jubilant Life Sciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Celanese AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Albemarle Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hikal Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dishman Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top